Results 321 to 330 of about 704,143 (399)
Integrated Multimodal Imaging for Transvenous Transpulmonary Atrial Pacing Lead Implantation in Fontan Patient. [PDF]
Flores MJ +6 more
europepmc +1 more source
We investigated cardiometabolic outcomes in patients treated with dapagliflozin 10 mg once daily or placebo after acute myocardial infarction according to LVEF at randomisation in the registry‐based, randomised DAPA‐MI trial. Regardless of baseline LVEF, dapagliflozin resulted in significant cardiometabolic benefits versus placebo, suggesting that ...
David Erlinge +19 more
wiley +1 more source
Tricuspid Valve Infective Endocarditis with Severe Tricuspid Regurgitation. [PDF]
Doyle R, Wilkinson M.
europepmc +1 more source
Follow-up of residual shunt after patent foramen ovale closure
Anzola +34 more
core +1 more source
Epicardial adipose tissue (EAT) has been linked to adverse remodelling and outcomes in aortic valve stenosis (AS), yet mechanisms remain unclear. In 137 patients with severe AS undergoing CMR before TAVR, higher EAT (≥46.5 ml/m2) was associated with impaired left atrial (LA) reservoir strain, while ventricular morphology, function and tissue ...
Judith Gronwald +10 more
wiley +1 more source
Echocardiographic findings in young adults with primary hypertension: A scoping review protocol. [PDF]
Mohamad Yamin LS +4 more
europepmc +1 more source
Novel mutation associated with non‐compaction ventricular myocardium: A case report
ESC Heart Failure, EarlyView.
Yan Li +4 more
wiley +1 more source
Abstract Purpose Finerenone, a highly selective non‐steroidal mineralocorticoid receptor antagonist, was approved for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (diabetic kidney disease, DKD). Finerenone reduced the composite endpoint of heart failure events and cardiovascular death in patients with heart ...
Kristian Hellenkamp +9 more
wiley +1 more source
Future of Valvular Heart Disease and Structural Heart Interventions: Why So Much Excitement? [PDF]
Beneki E, Grapsa J.
europepmc +1 more source
Circulating oxylipins predict mortality in heart failure with preserved ejection fraction
A targeted LC–MS lipidomics approach identified arterial 15‐keto PGF2a as associated with 5‐year mortality in 90 patients with HFpEF. Abstract Aims Heart failure with preserved ejection fraction (HFpEF) poses significant diagnostic, prognostic and therapeutic challenges, with high morbidity and mortality rates.
Vaishnavi Aradhyula +12 more
wiley +1 more source

